Implantable device for retaining live cells and providing nutrients thereto

Patent metadata

Field	Value
Publication number	US-10092387-B2
Application number	US-201615274229-A
Country	US
Kind code	B2
Filing date	Sep 23, 2016
Priority date	Sep 24, 2015
Publication date	Oct 9, 2018
Grant date	Oct 9, 2018

Abstract

An implantable medical device, a method of manufacturing, and a method of use are described. The implantable medical device includes an absorption bag connected by a cannula to a discharge bag. The implantable medical device also includes a reservoir external to the discharge bag and attached to a surface of the discharge bag. At least a portion of the absorption bag and at least a portion of a bottom surface of the reservoir are permeable to a predefined class of small molecules, such as molecular oxygen. The reservoir can retain live cells that rely on the small molecules for survival and growth. Based on concentration of the small molecules, the small molecules permeate into the absorption bag and are transported to the discharge bag for permeation into the reservoir, thereby providing a supply of the small molecules to the live cells.

First claim

What is claimed is:

1. An implantable medical device, comprising:
an absorption bag that comprises at least one portion permeable to oxygen and that defines an interior;
a discharge bag that comprises a first portion permeable to the oxygen and a second portion impermeable to the oxygen and that defines an interior;
a cannula that comprises a lumen and a portion impermeable to the oxygen, wherein the lumen of the cannula connects the interior of the absorption bag to the interior of the discharge bag; and
a reservoir that is external to the discharge bag, is on the first portion of the discharge bag, and comprises a wall, an opening, and a bottom, wherein:
the wall is impermeable to the oxygen and is attached to the first portion of the discharge bag,
the bottom is defined by the first portion of the discharge bag,
the reservoir is configured to retain live cells received through the opening and to provide the oxygen to the live cells based on oxygen permeation through the first portion of the discharge bag, and
the discharge bag and the absorption bag are dimensioned based on an expected oxygen consumption by the live cells.

2. The implantable medical device of claim 1 , wherein the live cells belong to a culture, and wherein the culture is retained by the reservoir.

3. The implantable medical device of claim 2 , wherein the culture comprises a hydrogel.

4. The implantable medical device of claim 3 , wherein the hydrogel comprises vinyl sulfone and cysteine, and wherein the live cells comprise islets.

5. The implantable medical device of claim 1 , wherein the absorption bag, the cannula, the discharge bag, and the reservoir are integrally formed with one another of silicone, and wherein the portion of the cannula impermeable to the oxygen is formed by a coating of parylene over the silicone.

6. The implantable medical device of claim 5 , wherein the second portion of the discharge bag is impermeable to the oxygen based on a coating of parylene over the silicone that defines the second portion, and wherein the coating of the parylene does not extend to the first portion of the discharge bag permeable to the oxygen.

7. The implantable medical device of claim 5 , wherein the wall of the reservoir comprises a coating of parylene over the silicone that defines the wall, and wherein the wall of the reservoir are impermeable to the oxygen based on the coating of parylene.

8. The implantable medical device of claim 5 , wherein a portion of the absorption bag is impermeable to the oxygen based on a coating of parylene over the silicone that defines the portion of the absorption bag.

9. The implantable medical device of claim 1 , wherein the reservoir has a cylindrical shape.

10. The implantable medical device of claim 9 , wherein an internal diameter of the reservoir is in the range of 1 mm to 20 mm.

11. The implantable medical device of claim 1 , wherein the wall of the reservoir has a height that falls in the range of 100 μm to 1 mm.

12. An implantable medical device, comprising: an absorption bag that comprises at least one portion permeable to a predefined class of small molecules and that defines an interior;
a discharge bag that comprises a first portion permeable to the small molecules and a second portion impermeable to the small molecules and that defines an interior;
a cannula that comprises a lumen and a portion impermeable to the small molecules, wherein the lumen of the cannula connects the interior of the absorption bag to the interior of the discharge bag; and
a means for retaining live cells and for providing the small molecules to the live cells based on permeation through the first portion of the discharge bag, wherein the means is external to the discharge bag, and located on the first portion of the discharge bag.

13. The implantable medical device of claim 12 , wherein the discharge bag and the absorption bag are dimensioned based on an expected consumption of the small molecules by the live cells.

14. The implantable medical device of claim 12 , wherein the means for retaining the live cells and for providing the small molecules to the live cells comprises a reservoir, wherein the reservoir is external to the discharge bag and comprises a wall, an opening, and a bottom, wherein the wall is impermeable to the small molecules and is attached to the first portion of the discharge bag, wherein the bottom is defined by the first portion of the discharge bag.

15. The implantable medical device of claim 12 , wherein the means for retaining the live cells and for providing the small molecules to the live cells comprises an irregular array of corrugations that are disposed on an external side of the first portion of the discharge bag.

16. The implantable medical device of claim 12 , wherein the means for retaining the live cells and for providing the small molecules to the live cells comprises a pattern of corrugations that are disposed on an external side of the first portion of the discharge bag.

17. The implantable medical device of claim 12 , wherein the live cells are disposed in a hydrogel, and wherein the means for retaining the live cells and for providing the small molecules to the live cells comprises an adhesion layer between the first portion of the discharge bag and the hydrogel.

Assignees

• California Inst Of Techn
• Hope City

Inventors

• Tai Yu-Chong
• Kang Dongyang
• Komatsu Hirotake
• Lin Henry K
• Mullen Yoko

Classifications

• C12M21/00

  Bioreactors or fermenters specially adapted for specific uses (digesters for manure A01C3/023; apparatus for PCR B01L7/52; destroying or transforming solid waste B09B3/00; methods for genetic engineering C12N15/00, C12Q1/68; nucleic acid amplification reactions C12Q1/6844) · CPC title

• A61F2/022 Primary

  Artificial gland structures using bioreactors (hemodialysis A61M1/16; hemofiltration A61M1/34; other extracorporeal blood treatment A61M1/36) · CPC title

• A61F2240/004

  Using a positive or negative model, e.g. moulds · CPC title